nature, it was possible to test only one style of implant in each category of treatment, and the lenses chosen were the Binkhorst 2-loop iridocapsular lens for extracapsular extraction and a modified Binkhorst 4-loop lens for intracapsular extraction (the Federov I lens). The Federov I lens was chosen because the participating surgeons were already familiar with this lens and had used it for more than five years' and because it was widely used in the United Kingdom at the time. The Shearing type of posterior chamber lens was not yet widely known.
It was appropriate to compare lens implantation with conventional intracapsular surgery and the use of contact lenses, which would eliminate the optical disadvantages of aphakic spectacles. If contact lenses could be fitted and tolerated universally, there would scarcely be a need for lens implantation. The choice of the type of contact lens, however, need not be restricted, since they can be and are freely exchanged, provided the best techniques and material are available to the patients in the study.
Although a reversal of trends has occurred in relation to the number of iris supported and posterior chamber lenses used,4 the latter is by no means trouble free.' There are many patients fitted with iris supported lenses who still require careful management based on sound facts. Furthermore, there are remarkably few well documented reports of the long term follow-up of intraocular lenses in general. So far years are of iris supported lenses,6 and only one has no loss of patients to follow-up. 7 The authors believe that this is the first randomised controlled trial to be reported, and, though the modes of treatment tested are no longer popular, the results of the study would still be useful and should provide both valid data to help formulate opinions and background information to test future claims.
The purpose of this paper is to report on:
(1) interim visual acuity, (2) complication rates, (3) corneal endothelial cell loss.
Patients and methods
The patients were recruited from a pool of cases requring surgery, the need for which is based on visual criteria. All eligible patients were given a detailed written account of the choices of treatment.
They were interviewed and given explanations, usually in the presence of a relative, and signed informed consent was obtained. Their age range was from 55-90 (Table 1) . Exclusion criteria aimed to eliminate patients with other ocular diseases likely to .the second eye in the study if the first eye of that patient had been assigned a contact lens.
SURGERY
The surgical method was standardised in a manual and approved by each participating surgeon. Minor variations were allowed to suit individual needs.
All the surgery was performed with the use of a Zeiss OpMic VI microscope. The 140-160°section was two-planed and had a short limbal-based flap. 8/0 virgin silk was used initially but after the first few months 10/0 monofilament interrupted sutures were used for all patients with the knot buried within the sclera. Two to three preplaced sutures were used, and closure was finished with three or four additional sutures. a-Chymotrypsin was used routinely for IC with implant (group B) but optional for patients over 70 years old without an implant (group A). For extracapsular extraction (group C) the standard 'can opener' technique was used for capsulotomy, and nuclear expression was followed by manual suction of the cortex by means of a coaxial or twin barrelled cannula which permitted simultaneous aspiration and infusion.
Two iridectomies were routinely performed for the implant groups after the second case of pupil block glaucoma had occurred.
Lens implantation was carried out only when an air bubble could be maintained in the anterior chamber, and the procedure was abandoned if there was vitreous loss. Preoperative medication included the use of intravenous mannitol for all patients destined for an implant who were less than 70 years old and had no contraindications to its use. All but two patients had general anaesthesia, which was of a uniform technique' with halothane and assisted respiration.
The patients were seen daily for five days or until their discharge, but scheduled postoperative assessments were made at 48 hours, the fifth day, one month, six months, and thereafter at each anniversary of surgery. The clinical assessment was made by research registrar trained in ophthalmic observations. The visual acuity was assessed independently by a trained optician (optometrist) who had no professed bias towards either mode of treatment. Masking procedures were used in endothelial cell counting, in reading fluorescein angiograms, and where possible in reading the end point of corneal thickness measurements. Masking was attempted in refraction, but in practice it was difficult and not always practicable to do this for large numbers of patients. However, the assessment of corrected visual acuity was carried out by a forced choice method as defined in the manual and was used throughout the study. The method was similar to the one used in the Diabetic Retinopathy Study. 9 An experienced contact lens practitioner fitted all contact lenses at six weeks to two months, and related complications were seen by a visiting consultant in contact lenses. A nurse practitioner, herself a CL wearer, helped patients manage their CL and had a telephone which enabled patients to contact her directly. Uncomplicated cases with daily-wear hard lenses were seen as often as necessary until tolerance was established. Thereafter, they were seen at the scheduled visits. Soft daily-wear and extended-wear lenses were checked as often as needed until a quiet stage was reached, and thereafter at three-monthly intervals for extended-wear cases.
COMPLICATIONS
Based on the experience of a Pilot Study' 27 known events or complications were listed which required either additional hospital visits or treatment. In general, postoperative complications were defined as follows if they did not conform to those listed in Table 5 : as an event (1) needing additional surgical intervention, or (2) related to the surgery and reducing the visual acuity by two lines of the Snellen chart to 6/12 (20/40), or (3) requiring prolonged additional medication.
Additional events were recorded on these criteria. All patients suffering a drop in acuity to 6/12 (20/40) or by two lines of Snellen with no obvious cause had fluorescein angiography performed, which was read independently. Cystoid macular oedema (CMO) was recorded only if it was proved angiographically.
ENDOTHELIAL CELL COUNTS
Corneal endothelial cells were photographed with a Nikon non-contact specular microscope and counts derived by grid counting. The method has been described"' and its precision estimated." Cell densities were estimated before surgery, at one month, six months, and yearly after operation. Masking procedures were used for counting.
Results
Three hundred and twenty-seven patients and 333 eyes were recruited from 15th January 1980 to 31 June 1983. The number of patients asked initially was not known, but 400 patients were formally approached and 67 elected to have lens implants. Six patients allowed both eyes to be randomised for the trial. The mean age of patients was 72 years with a range as shown in Table 1 . The numbers in each group are shown in Table 3 .
DEATH AND LOSS TO FOLLOW-UP
One year from the beginning of the study two patients each from groups A and B had died, but by the three-year stage the number dead had increased to 21 (A=6, B=7, C=8). However, apart from death there was no loss to follow-up. RAN 
DOMISATION
The numbers of patients treated by each surgeon in the three treatment groups are shown in Table 3 .
There was one deviation from protocol regarding the randomisation. In one case surgeon III changed from EC to IC extraction because the pupil would not dilate sufficiently to permit him to use his technique. OPERATIVE 
COMPLICATIONS
The intraoperative complications are listed in Table  4 . Surgeon III contributed only 17 cases in the last year of the study, and all his cases were entered within his first six months of joining.
Vitreous loss was the most serious complication and occurred more frequently in EC than in IC surgery. Capsule rupture occurred more frequently during routine intracapsular surgery than when it was combined with lens implantation. In no case where ruptured capsule had occurred was residual lens year, and at each time point the amount of cell loss tended to be greater for group C than for the other two groups. Variance analysis of the results of the three groups showed a significant difference at each of the three time points (Table 9 ). Only the patients of surgeon I were included to -reduce potential variables in surgical techniques and because he contributed more cases than the other two combined.
The overall results suggest that both implant groups lost more cells than the non-implant group, and, though the IC group with implant did slightly better than the EC group in the early stages, there was no significant difference between the two implant groups at one year. These results were not altered by the inclusion of cases from surgeons II and III.
VISUAL ACUITY
The visual acuities at one month ( Fig. 1) and at one year (Fig. 2) are grouped according to levels of vision in Table 10 . At the one-month stage the acuities for group A were obtained by spectacle correction, but the one-year acuities were obtained by a combination of contact lenses and additional spectacle correction. More eyes achieved 6/9 (20/30) acuity or better in group A than in the others at one month, but this trend was reversed at one year (Table 10) . Ninetyseven patients in group A were still wearing CL at the end of one year (44 daily wear and 53 extended wear). Twenty-three patients had 6/18 (20/60) acuity or less at the one-year stage. The causes of poor visual acuity and the postoperative complications are listed in Table 11 .
Discussion
The study design would have been improved if a fourth arm of EC extraction without implant could have been introduced into the randomisation. This mode of treatment at the time of inception of the study. A weakness of the study is that there is no allowance for incorporating innovations which may be considered improvements in treatment. A strength is the standardized conditions, which were maintained more or less constant throughout the study. Critics of the Federov I implant used in conjunction with IC extraction argued that the anterior loops can cause intermittent corneal touch, but a study using high-speed cinefilm did not confirm this impression in cases without complications.'2 Results of interim reviews monitored by an inde- l' 6/6 6/9
first six months of the study. Although he had been using EC extraction routinely for two years, it is still possible that in the first six months his surgical techniques and operating condition had not yet been perfected. These factors may have accounted for the higher rate of complications than later on. A review of the surgical notes showed that all cases of vitreous loss in group C occurred while cortical lens matter was being removed and before the stage of lens implantation had been reached. The most numerous postoperative complications were raised pressure and cystoid macular oedema. An arbitrary level of pressure was selected, and any eye with a pressure of 26 mmHg or greater was considered to have raised pressure, which occurred more frequently in group B than in groups A and C (p<0.001). In group B a-chymotrypsin was used routinely to facilitate delivery of the cataract because the pupil was often poorly dilated. Only Mydrilate (cyclopentolate 1 %) was used to enlarge the pupil so that the iris could remain responsive to intracameral Miochol (acetylcholine 1% and mannitol 3%) during surgery. A small pupil was thus obtained to maintain the iris supported implants in the correct position. However, even allowing for the fact that only 70% of eyes in group A had received a-chymotrypsin, the proportion of eyes developing raised pressure in group B was still higher than in group A. Significantly, more eyes developed raised pressure if achymotrypsin was used, but there was no correlation between the use of a-chymotrypsin and the level of the rise in pressure. In all cases the pressures were controlled or settled spontaneously by the six-month stage.
By doing fluorescein angiography only when there is a reduction of vision, our method of assessment would detect only clinical CMO. This complication occurred in group B (IC+implant) more commonly than in the other two groups, but the difference is not statistically significant. In groups A, B, and C there were only two, three, and one cases respectively which remained unresolved by the one-year stage. Interestingly, all but two of the 14 cases with CMO in group C had intact capsules, which clearly are not always an effective protection against this complication.
Nine eyes with implants were noted to have some shallowing of the anterior chamber, and eight of them occurred in group B. In half of the eyes the cause was not known with certainty, but in half the shallowing was due to displacement (without subluxation) of the implant. Although the majority resolved spontaneously, that this should occur so frequently in group B is a worrying feature of this type of implant.
Some complications occurred more than once in the same eye, and Table 6 distinguishes between episodes recorded and the number of eyes affected. Fortunately the number of eyes developing the same complication more than once is limited. Some complications are not expected in the first year, and thus no case of bullous keratopathy was recorded until after the two-year stage was reached. Likewise only four cases had capsule opacities affecting visual acuity, but the aggregate total was 19 by the time the study had been in progress for 4-5 years.
If serious complications are considered, there was no significant difference between groups except for raised pressure, because of small numbers; but, as regards the number of all the complications, group B had far more than group A or C.
If a grading system" was used to assign a numerical score for each complication, more points being awarded the more serious the event, group B scored significantly higher than either group C or A. Thus either by looking at the frequency of occurrence of complications or by the use of a grading system group B seemed to be doing less well than the other two groups.
From the point of view of visual acuity the difference between groups is not significant or great, but the trend suggests that, at the one-year stage, group C is doing better than either group B or group A.
Almost all the patients in group A had been fitted with a contact lens by the one-year stage, and the proportion of eyes achieving 6/9 (20/30) acuity or better had diminished in comparison with the onemonth stage, when the visual acuities were obtained through spectacle correction (Table 10 ).
In our study of cell loss only central corneal densities were estimated, as the number of patients involved would make a study of morphology logistically impossible. At one month cell loss would reflect intraoperative factors. Although cell loss was significantly greater with the EC group, it was only 16.3%, and, with the mean loss of 10-7 and 10*9% respectively in the other groups, the results are within current claims, 14 '" which suggests that the surgery has been competently carried out. It is, however, a little surprising that the loss in the IC group with a twoplane iris supported lens was significantly less than in the EC group, which suggests that it is technically possible to execute the manoeuvres of implanting an iris-supported lens without undue trauma. That the implant groups should lose significantly more cells subsequently is worrying, but it is comforting to find that by the one-year stage there is no significant difference between the IC groups with implant and the EC group.
Many variables may affect cell loss, and a more detailed discussion will be presented in a separate report on cell loss after a longer follow-up, which is clearly necessary to determine whether increased loss with time is clinically important. Cell loss apart, the evidence thus far, from the complication and visual acuity data, suggests that lens implantation with extracapsular extraction compares favourably with intracapsular extraction and the use of a contact lens. However, significantly more complications occurred in eyes with iris supported lenses, amply confirming current opinion that such lenses should be avoided for new cases of lens implantation.
